Europe Cell and Gene Therapy Manufacturing QC Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy, Gene Therapy), By Scale (Pre-commercial/R&D, Commercial), By Mode (Contract, In-house), By Workflow (Cell Processing, Cell Banking, Fill & Finish, Raw Material Testing, Vector Production, Others), By Process (Upstream, Downstream), By End User (Pharmaceutical, Biopharmaceutical/Biotechnology Companies, CMOs), By Technology (FACS, ELISA, Chromatography, NGS, PCR, Others), By Country (U.K., Germany, France, Italy, Russia, Nordic, Benelux, Rest of Europe), Forecasts, 2026–2034.

Last Updated: July 08, 2026 | Author: Debashree B | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Europe Cell and Gene Therapy Manufacturing QC Market Size Analysis
    1. Introduction
    2. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
      1. Cell Therapy
        1. CAR-T
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        2. CAR-NK
        3. B-Cell
        4. Others
      2. Gene Therapy
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Other
        2. Non-Viral
    3. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
      1. Pre-commercial/ R&D Manufacturing
      2. Commercial Scale Manufacturing
    4. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. In-house Manufacturing
    5. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
      1. Cell Processing
      2. Cell Banking
      3. Fill & Finish Operations
      4. Raw Material Testing
      5. Vector Production
      6. Other Workflows
    6. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Process 2022 (USD MILLION/ Units)
      1. Upstream Processes
      2. Downstream Processes
    7. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
      1. Pharmaceutical Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      2. Biopharmaceutical / Biotechnological Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      3. Contract Manufacturing Organizations
        1. Small Size
        2. Medium Size
        3. Large Size
    8. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
      1. Fluorescence-Activated Cell Sorting (FACS)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Chromatography
      4. Next-Generation Sequencing (NGS)
      5. Polymerase Chain Reaction (PCR)
      6. Others
  7. Europe Europe Cell and Gene Therapy Manufacturing QC Market Size Analysis
    1. Introduction
    2. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
      1. Cell Therapy
        1. CAR-T
          1. Autologous CAR-T
          2. Allogeneic CAR-T
        2. CAR-NK
        3. B-Cell
        4. Others
      2. Gene Therapy
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Other
        2. Non-Viral
    3. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
      1. Pre-commercial/ R&D Manufacturing
      2. Commercial Scale Manufacturing
    4. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. In-house Manufacturing
    5. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
      1. Cell Processing
      2. Cell Banking
      3. Fill & Finish Operations
      4. Raw Material Testing
      5. Vector Production
      6. Other Workflows
    6. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Process 2022 (USD MILLION/ Units)
      1. Upstream Processes
      2. Downstream Processes
    7. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
      1. Pharmaceutical Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      2. Biopharmaceutical / Biotechnological Companies
        1. Small Size
        2. Medium Size
        3. Large Size
      3. Contract Manufacturing Organizations
        1. Small Size
        2. Medium Size
        3. Large Size
    8. Europe Cell and Gene Therapy Manufacturing QC Market Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
      1. Fluorescence-Activated Cell Sorting (FACS)
      2. Enzyme-Linked Immunosorbent Assay (ELISA)
      3. Chromatography
      4. Next-Generation Sequencing (NGS)
      5. Polymerase Chain Reaction (PCR)
      6. Others
    9. U.K.
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    10. Germany
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    11. France
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    12. Italy
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    13. Russia
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    14. Nordic
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    15. Benelux
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
    16. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      3. Market Size & Forecast By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      4. Market Size & Forecast By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      5. Market Size & Forecast By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      6. Market Size & Forecast By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      7. Market Size & Forecast By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      8. Market Size & Forecast By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
  8. Competitive Landscape
    1. Europe Cell and Gene Therapy Manufacturing QC Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  9. Market Players Assessment
    1. Lonza
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Pharmaron
    3. Eurofins Scientific
    4. Merck KGaA
    5. Catalent Inc.
    6. Charles River Laboratories
    7. Thermo Fisher Scientific Inc.
    8. WuXi AppTec
    9. BioAgilytix Labs
    10. Alcami Corporation
    11. IQVIA Inc.
    12. SGS Société Générale de Surveillance SA
    13. and others.
  10. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  11. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  12. Disclaimer

We are featured on: